MolDX: Molecular Diagnostic Tests (MDT)
J15 · Effective Oct 1, 2015
18 active Medicare policies list 0117U, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
5 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 0117U |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 0117U |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 0117U |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 |
J15 · Effective Oct 8, 2023
National · Effective Jan 1, 2026
National · Effective Feb 19, 2026
National · Effective Jan 1, 2026
J5 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J9 · Effective Jan 1, 2026
National · Effective Jan 22, 2026
| Covered |
| Policy | Effective | Status of 0117U |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 0117U |
|---|---|---|
| Pharmacogenomics Testing | Not recorded | Covered |